Receipt of systemic corticosteroids during asthma visits to US emergency departments, 2007-2009
- PMID: 23402384
- PMCID: PMC11295054
- DOI: 10.3109/02770903.2013.769269
Receipt of systemic corticosteroids during asthma visits to US emergency departments, 2007-2009
Abstract
Background: National Asthma Education and Prevention Program recommended emergency department (ED) asthma treatment includes both providing systemic corticosteroids in the ED and a steroid prescription at discharge.
Objective: To examine the prevalence of three types of substandard ED asthma care-providing a discharge prescription only, providing corticosteroids in the ED only, and providing neither- and how care varies with exacerbation severity.
Methods: We used the National Hospital Ambulatory Medical Care Survey-Emergency Department (NHAMCS-ED) (2007, 2008, and 2009) to identify ED asthma visits (International Classification of Diseases-9(th) Revision Clinical Modification (ICD-9-CM codes 493.xx)) for patients aged 1 to <65 years. The primary outcome was the percent of visits receiving each type of substandard care, both overall and by exacerbation severity. Multinomial logistic regressions with predictive margins were used to obtain estimates adjusted for patient, visit, and hospital characteristics.
Results: For 27.1% (confidence interval (CI): 24.0-30.2%) of visits, patients received corticosteroids both in the ED and as a discharge prescription. A discharge prescription only was provided for 12.3% of visits (CI: 10.2-14.6%), corticosteroids were provided in the ED only for 18.2% (CI: 15.6-21.2%), and no corticosteroids were provided for 42.4% (CI: 38.8-46.2%). Even among visits by patients with abnormal overall respiratory status (fast respiratory rates, pulse oximetry values <97%, or both), only 32.3% (CI: 27.8-36.8) were provided corticosteroids both in the ED and as a prescription, while the remainder received some type of substandard care. Adjusted and unadjusted results were similar.
Conclusions: Substandard ED asthma care is common, even among visits by patients with more severe asthma exacerbations.
Conflict of interest statement
The authors have no conflicts of interest to disclose.
The findings and conclusions in this report are those of the authors and do not necessarily represent the official position of the Centers for Disease Control and Prevention. The authors have no financial relationships relevant to this article to disclose. No funding or research support was received for this research.
Figures
References
-
- National Center for Health Statistics. National Hospital Ambulatory Medical Care Survey. 2009. Emergency department summary tables. Available at: http://www.cdc.gov/nchs/data/ahcd/nhamcs_emergency/2009_ed_web_tables.pdf. Accessed November 8, 2012.
-
- National Asthma Education and Prevention Program. National Heart LaBI, National Institutes of Health: U.S. Department of Health and Human Services; Expert Panel Report 3: Guidelines for the Diagnosis and Management of Asthma. August 28, 2007.
-
- Rowe B, Spooner C, Ducharme F, Bretzlaff J, Bota G. Corticocorticosteroids for preventing relapse following acute exacerbations of asthma. Cochrane Database of Systematic Reviews 2007, Issue 3. Art. No. CD000195. - PubMed
-
- Bekmezian A, Hersh AL, Maselli JH, Cabana MD. Pediatric emergency departments are more likely than general emergency departments to treat asthma exacerbation with systemic corticosteroids. J Asthma 2011; 48(1):69–74. - PubMed
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical